|
1
|
General Atlantic
New York
|
$133M
|
–
|
–
|
–
|
|
|
2
|
Fidelity Investments
Boston,
Massachusetts
|
$95.4M
|
+$435K
|
+27,023
|
+0.5%
|
|
|
3
|
Foresite Capital Management IV
Larkspur,
California
|
$77.6M
|
–
|
–
|
–
|
|
|
4
|
venBio Partners
San Francisco,
California
|
$75.5M
|
–
|
–
|
–
|
|
|
5
|
Viking Global Investors
Stamford,
Connecticut
|
$64.3M
|
–
|
–
|
–
|
|
|
6
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$58.1M
|
–
|
–
|
–
|
|
|
7
|
|
$36M
|
-$17.2M
|
-1,065,100
|
-34%
|
|
|
8
|
Deerfield Management
New York
|
$35.5M
|
–
|
–
|
–
|
|
|
9
|
Commodore Capital
New York
|
$33.6M
|
–
|
–
|
–
|
|
|
10
|
Novo Holdings A/S
Hellerup,
Denmark
|
$30.4M
|
–
|
–
|
–
|
|
|
11
|
Cormorant Asset Management
Boston,
Massachusetts
|
$25.6M
|
-$190K
|
-11,800
|
-0.8%
|
|
|
12
|
Paradigm Biocapital Advisors
New York
|
$18.7M
|
+$17.1M
|
+1,062,911
|
New
|
|
|
13
|
5AM Venture Management
San Francisco,
California
|
$14M
|
–
|
–
|
–
|
|
|
14
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$13.5M
|
+$2.92M
|
+181,228
|
+31%
|
|
|
15
|
Soleus Capital Management
Greenwich,
Connecticut
|
$12.9M
|
-$1.32M
|
-81,684
|
-10%
|
|
|
16
|
Octagon Capital Advisors
New York
|
$11.8M
|
-$1.57M
|
-97,220
|
-13%
|
|
|
17
|
Rock Springs Capital Management
Baltimore,
Maryland
|
$11M
|
–
|
–
|
–
|
|
|
18
|
Sofinnova Investments
Menlo Park,
California
|
$10.3M
|
-$127K
|
-7,871
|
-1%
|
|
|
19
|
Sphera Funds Management
Tel Aviv,
Israel
|
$5.45M
|
-$1.19M
|
-73,925
|
-19%
|
|
|
20
|
Patient Square Capital
Menlo Park,
California
|
$4.3M
|
-$19.5K
|
-1,213
|
-0.5%
|
|
|
21
|
Rosalind Advisors
Toronto,
Ontario, Canada
|
$3.94M
|
–
|
–
|
–
|
|
|
22
|
|
$3.54M
|
+$133K
|
+8,224
|
+4%
|
|
|
23
|
TFG Asset Management
Grand Cayman,
Cayman Islands
|
$3.31M
|
+$984K
|
+61,105
|
+48%
|
|
|
24
|
TD Asset Management
Toronto,
Ontario, Canada
|
$1.75M
|
+$345K
|
+21,388
|
+27%
|
|
|
25
|
Northern Trust
Chicago,
Illinois
|
$1.68M
|
+$135K
|
+8,393
|
+10%
|
|
